| | |
| Age, mean (sd) | 58.07 (1.4) | Male, % | 46 (51.7%) | Black, % | 67 (75.3%) | History of HTN, % | 71 (79.8%) | Antihypertensive medications, % | 44 (49.4%) | On antithrombotics (AP/AC), % | 32 (36%) | History of chronic daily alcohol use, % | 23 (25.8%) | Positive urine tox screen, % | 17 (19.1%) | ICH score on admission, median | 1 (0–3) | Presenting GCS, median | 14 (4–15) | First SBP, mean (sd) | 189.7 (3.7) | First DBP, mean (sd) | 111.2 (2.6) | Baseline NIHSS, median (range) | 15 (0–40) | Glucose on admission, mean (sd) | 144.65 (6.7) | ICH location | | Basal ganglia | 41 (46.1%) | Thalamus | 18 (20.2%) | Pons | 5 (5.6%) | Cerebellum | 5 (5.6%) | Lobar | 18 (20.2%) | Other | 1 (1.1%) | ICH tentorial location | | Supratentorial | 77 (86.5%) | Infratentorial | 11 (12.4%) | Total | 88 (98.9%) | IVH, % | 42 (47.2%) | Hydrocephalus, % | 35 (39.3%) | Edema on initial HCT, % | 62 (69.7%) | Spot sign on CTA, % | 10 (11.2%) | Dot sign present on CTA, % | 16 (18%) | New IVH, % | 6 (6.7%) | ICH expansion, % | 42 (47.2%) | Evacuation, % | 12 (13.5%) | EVD placed, % | 28 (31.5%) | Did patient receive vitamin k? % | 10 (11.2%) | Did patient receive FFP? % | 14 (15.7%) | Did patient receive platelets? % | 17 (19.1%) | Did patient receive NOVO7? % | 4 (4.5%) | IVtPA, % | 5 (5.6%) | In-hospital infection, % | 33 (37.1%) | In-hospital DVT, % | 2 (2.2%) | In-hospital UTI, % | 24 (27%) | In-hospital bacteremia, % | 12 (13.5%) | Best 24 hr GCS, median | 13 (3–15) | Follow-up volume, median (range) | 12.3 (0–402) | 24-hour ICH score, median | 1.0 (0–5) | Transfer patient, % | 8 (9%) | Initial shift on HCT, median (range) | 2.0 (0–17) | ICH initial volume, median (range) | 12.8 (0–186) | ICH volume 24 hrs, median (range) | 11 (0–402) | ICH volume growth in 24 hrs, median (range) | 0 (−107–346) | Length of stay, median (range) | 10 (2–86) | mRS on discharge, median (range) | 4 (1–6) | Death, % | 14 (15.7%) |
|
|